Bulking Agents for the Treatment of Stress Urinary Incontinence in Females
A Single-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Bulkamid® and Contigen® as Bulking Agents for the Treatment of Stress Urinary Incontinence in Females
Sponsor: Contura
A NA clinical study on Stress Urinary Incontinence, this trial is completed. The trial is conducted by Contura and has accumulated 9 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Mar 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Mar 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Sep 2019 — Mar 2020 [monthly]
Completed NA
-
Jun 2018 — Sep 2019 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Apr 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Contura
- Regulatory and Clinical Research Institute Inc
For direct contact, visit the study record on ClinicalTrials.gov .